TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jul 2025

Income Metrics

Revenue 1.1B
Gross Profit 509.7M 45.30%
Operating Income 412.6M 36.67%
Net Income 395.3M 35.14%
EPS (Diluted) $0.41

Balance Sheet Metrics

Total Assets 10.1B
Total Liabilities 883.4M
Shareholders Equity 9.2B
Debt to Equity 0.10

Cash Flow Metrics

Operating Cash Flow 432.3M
Free Cash Flow 350.8M

Revenue & Profitability Trend

Copart Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i4.6B4.2B3.9B3.5B2.7B
Cost of Goods Sold i2.5B2.3B2.1B1.9B1.3B
Gross Profit i2.1B1.9B1.7B1.6B1.3B
Gross Margin % i45.2%45.0%44.9%45.9%49.9%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i402.9M335.2M250.4M231.2M206.7M
Other Operating Expenses i-----
Total Operating Expenses i402.9M335.2M250.4M231.2M206.7M
Operating Income i1.7B1.6B1.5B1.4B1.1B
Operating Margin % i36.5%37.1%38.4%39.3%42.2%
Non-Operating Items
Interest Income i-----
Interest Expense i---16.7M20.2M
Other Non-Operating Income20.0M-3.1M1.8M-17.4M5.7M
Pre-tax Income i1.9B1.7B1.6B1.3B1.1B
Income Tax i347.2M352.3M316.6M250.8M185.4M
Effective Tax Rate % i18.3%20.5%20.4%18.7%16.5%
Net Income i1.5B1.4B1.2B1.1B936.5M
Net Margin % i33.3%32.2%32.0%31.1%34.8%
Key Metrics
EBITDA i1.9B1.8B1.6B1.5B1.3B
EPS (Basic) i-$1.42$1.30$1.15$0.99
EPS (Diluted) i-$1.40$1.28$1.13$0.98
Basic Shares Outstanding i-960739000953574000949676000945008000
Diluted Shares Outstanding i-960739000953574000949676000945008000

Income Statement Trend

Copart Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i2.8B1.5B957.4M1.4B1.0B
Short-term Investments i2.0B1.9B1.4B0-
Accounts Receivable i201.0M173.7M157.1M137.2M97.2M
Inventory i39.7M43.6M40.0M58.8M45.0M
Other Current Assets46.4M33.9M26.3M18.7M14.3M
Total Current Assets i5.8B4.4B3.3B2.2B1.7B
Non-Current Assets
Property, Plant & Equipment i99.7M116.3M108.1M116.3M119.5M
Goodwill i1.1B1.1B851.3M858.6M757.3M
Intangible Assets i62.8M74.1M62.7M54.7M45.9M
Long-term Investments-----
Other Non-Current Assets57.9M129.4M65.8M47.7M41.8M
Total Non-Current Assets i4.3B4.0B3.5B3.1B2.9B
Total Assets i10.1B8.4B6.7B5.3B4.6B
Liabilities
Current Liabilities
Accounts Payable i214.4M193.3M180.0M187.2M163.2M
Short-term Debt i19.9M21.3M21.5M21.8M22.5M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i683.3M628.6M492.8M440.9M421.0M
Non-Current Liabilities
Long-term Debt i83.9M97.4M99.0M97.7M495.6M
Deferred Tax Liabilities i80.6M93.7M89.5M80.1M64.0M
Other Non-Current Liabilities-24.5M---
Total Non-Current Liabilities i200.1M250.6M257.7M242.4M611.9M
Total Liabilities i883.4M879.2M750.4M683.3M1.0B
Equity
Common Stock i97.0K96.0K96.0K96.0K24.0K
Retained Earnings i8.1B6.5B5.2B4.0B2.9B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i9.2B7.5B6.0B4.6B3.5B
Key Metrics
Total Debt i103.7M118.7M120.5M119.5M518.1M
Working Capital i5.1B3.8B2.8B1.8B1.3B

Balance Sheet Composition

Copart Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i1.5B1.4B1.2B1.1B936.5M
Depreciation & Amortization i217.8M190.3M159.7M138.6M123.1M
Stock-Based Compensation i38.0M35.2M39.7M39.0M40.9M
Working Capital Changes i59.1M-89.6M-50.2M-120.4M-111.9M
Operating Cash Flow i1.8B1.5B1.4B1.2B980.7M
Investing Activities
Capital Expenditures i-537.2M-506.8M-482.7M-333.1M-460.5M
Acquisitions i-8.4M8.9M-2.7M-109.2M-5.0M
Investment Purchases i-4.0B-4.1B-1.4B-374.9M0
Investment Sales i4.0B3.6B0374.9M0
Investing Cash Flow i-587.4M-940.1M-1.9B-442.3M-465.5M
Financing Activities
Share Repurchases i----0
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-49.0K-10.8M-33.9M-417.3M-1.1M
Financing Cash Flow i-5.3M-28.2M-28.1M-420.4M-7.3M
Free Cash Flow i1.2B961.6M847.6M839.2M527.9M
Net Change in Cash i1.3B529.1M-523.3M301.6M507.9M

Cash Flow Trend

Copart Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 28.37
Forward P/E 25.93
Price to Book 4.75
Price to Sales 9.39
PEG Ratio 1.38

Profitability Ratios

Profit Margin 33.41%
Operating Margin 36.78%
Return on Equity 18.48%
Return on Assets 11.84%

Financial Health

Current Ratio 8.42
Debt to Equity 1.13
Beta 1.03

Per Share Data

EPS (TTM) $1.59
Book Value per Share $9.50
Revenue per Share $4.81

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
cprt44.1B28.374.7518.48%33.41%1.13
Cintas 81.9B45.0217.1742.19%17.54%56.25
Global Payments 21.3B14.980.946.59%14.20%71.17
Rb Global 19.9B52.983.777.39%9.68%76.45
Rentokil Initial plc 14.5B41.9212.645.13%4.46%115.51
Ul Solutions 14.5B44.5713.2736.55%11.08%72.33

Financial data is updated regularly. All figures are in the company's reporting currency.